Literature DB >> 20724180

Application of the Three Rs to challenge assays used in vaccine testing: tenth report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement.

Maggy Jennings1, David B Morton, Emmanuelle Charton, Jane Cooper, Coenraad Hendriksen, Stella Martin, Michael C Pearce, Scott Price, Keith Redhead, Nick Reed, Hugh Simmons, Stephen Spencer, Hilary Willingale.   

Abstract

This report aims to facilitate the implementation of the Three Rs (reduction, refinement and replacement) in the testing of vaccines for regulatory and other purposes. The focus is predominantly on identification of reduction and refinement opportunities in batch potency testing but the principles described are widely applicable to other situations that involve experimental infections of animals. The report should also help to interpret the requirements of the European Pharmacopoeia with regard to the use of alternative tests, humane endpoints and other refinements. Two specific worked examples, for batch potency testing of Clostridium chauvoei and canine leptospira, with recommendations for harmonisation of international test requirements for these and other vaccines, are provided as appendices online.
Copyright © 2009. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724180     DOI: 10.1016/j.biologicals.2010.04.004

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  7 in total

1.  Core body temperature as adjunct to endpoint determination in murine median lethal dose testing of rattlesnake venom.

Authors:  Charles C Cates; James G McCabe; Gregory W Lawson; Marcelo A Couto
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

2.  Markers for predicting death as an outcome for mice used in infectious disease research.

Authors:  Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2011-12       Impact factor: 0.982

3.  Hypothermic endpoint for an intranasal invasive pulmonary aspergillosis mouse model.

Authors:  Trinka W Adamson; Diana Diaz-Arevalo; Tracey M Gonzalez; Xueli Liu; Markus Kalkum
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

4.  The importance of animal models in tuberculosis vaccine development.

Authors:  Armando Acosta; Mohd Nor Norazmi; Rogelio Hernandez-Pando; Nadine Alvarez; Reinier Borrero; Juan F Infante; Maria E Sarmiento
Journal:  Malays J Med Sci       Date:  2011-10

5.  Evaluation of Infrared Thermography for Temperature Measurement in Adult Male NMRI Nude Mice.

Authors:  Kerstin Fiebig; Thomas Jourdan; Martin H Kock; Roswitha Merle; Christa Thöne-Reineke
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-09-12       Impact factor: 1.232

6.  Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions.

Authors:  Jodie Kulpa-Eddy; Geetha Srinivas; Marlies Halder; Richard Hill; Karen Brown; James Roth; Hans Draayer; Jeffrey Galvin; Ivo Claassen; Glen Gifford; Ralph Woodland; Vivian Doelling; Brett Jones; William S Stokes
Journal:  Procedia Vaccinol       Date:  2011-12-23

Review 7.  Opportunities for Refinement of Non-Human Primate Vaccine Studies.

Authors:  Mark J Prescott; Carolyn Clark; William E Dowling; Amy C Shurtleff
Journal:  Vaccines (Basel)       Date:  2021-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.